Clover Health Investments, Corp. (“Clover” or “the Company”), which operates next-generation Medicare Advantage plans, has entered into a definitive agreement to become publicly traded via a merger with Social Capital Hedosophia Holdings Corp. III. The SPAC is led by early Facebook executive Chamath Palihapitiya.
Related Posts
Panacea Files Investor Presentation on Nuvation Bio
In addition to the approximately $144 million held in Panacea's trust (assuming no redemptions), a group of premier healthcare investors has committed to participate in concurrent equity financings totaling slightly more than $500 million at $10 per share.
Landcadia Sets Dec. 18 Vote on Golden Nugget Merger
If approved, the combined company would have a valuation of about $745 million.
Zaoui Brothers Take U.K. Drugmaker Startup Public Via SPAC
BenevolentAI will combine with Odyssey Acquisition SA, a 300 million-euro blank check company that the Zaoui brothers listed on Euronext Amsterdam.